Genetic mutations associated with acute myeloid leukemia can also be detected in age-related clonal hematopoiesis, making confident assignment of detected variants to malignancy challenging particularly in the post-treatment setting. This has implications for measurable residual disease monitoring, where the relationship between sequencing and flow cytometry is also imperfect. We show, using whole-genome-sequencing informed patient-personalized single-cell DNA and antibody-oligonucleotide sequencing, that it is possible to resolve immunophenotypic identity of clonal architecture.
Laura W. Dillon, Jack Ghannam, Chidera Nosiri, Gege Gui, Meghali Goswami, Katherine R. Calvo, Katherine E. Lindblad, Karolyn A. Oetjen, Matthew Wilkerson, Anthony R. Soltis, Gauthaman Sukumar, Clifton L. Dalgard, Julie Thompson, Janet Valdez, Christin B. DeStefano, Catherine Lai, Adam Sciambi, Robert Durruthy-Durruthy, Aaron Llanso, Saurabh Gulati, Shu Wang, Aik Ooi, Pradeep K. Dagur, J. Philip McCoy, Patrick Burr, Yuesheng Li, Christopher S. Hourigan
